India's two main vaccines -- Bharat Biotechs Covaxin and Serum Institute of India's Covishield -- on Wednesday got the nod for regular market authorisation.
Bharat Biotech has urged healthcare workers to ensure that only Covaxin is administered to individuals in the 15-18 years age group.
Hyderabad-based vaccine manufacturer Bharat Biotech said on Saturday that its trials for Covaxin booster dose have shown 'long-term safety with no serious adverse events'.
Vaccine maker Bharat Biotech on Wednesday clarified that Paracetamol or pain killers are not recommended for teenagers after being vaccinated with Covaxin.
India supplied humanitarian assistance consisting of 5,00,000 Covaxin doses to Afghanistan on Saturday, the Ministry of External Affairs said.
Tamil Nadu health department will be inoculating 33.2 lakh students with Covaxin from January 3 onwards.
Hyderabad based vaccine manufacturer Bharat Biotech on Thursday announced that BBV152 (Covaxin), its whole-virion inactivated COVID-19 vaccine candidate, has proven to be safe, well-tolerated, and imm
As the vaccination process for the teens aged 15 to 18 years will commence from January 3 across the nation, the government has said only Covaxin will be administered.